Ligand Pharmaceuticals Statistics
Total Valuation
BOM:544453 has a market cap or net worth of INR 4.38 billion. The enterprise value is 4.47 billion.
Market Cap | 4.38B |
Enterprise Value | 4.47B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
BOM:544453 has 14.16 million shares outstanding. The number of shares has decreased by -0.00% in one year.
Current Share Class | 14.16M |
Shares Outstanding | 14.16M |
Shares Change (YoY) | -0.00% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 73.51% |
Owned by Institutions (%) | n/a |
Float | 3.75M |
Valuation Ratios
The trailing PE ratio is 9.25.
PE Ratio | 9.25 |
Forward PE | n/a |
PS Ratio | 2.84 |
PB Ratio | 4.03 |
P/TBV Ratio | 4.04 |
P/FCF Ratio | 50.94 |
P/OCF Ratio | 18.34 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.77, with an EV/FCF ratio of 51.94.
EV / Earnings | 12.83 |
EV / Sales | 2.90 |
EV / EBITDA | 8.77 |
EV / EBIT | 9.46 |
EV / FCF | 51.94 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.13.
Current Ratio | 1.79 |
Quick Ratio | 1.71 |
Debt / Equity | 0.13 |
Debt / EBITDA | 0.28 |
Debt / FCF | 1.66 |
Interest Coverage | 30.99 |
Financial Efficiency
Return on equity (ROE) is 38.12% and return on invested capital (ROIC) is 28.12%.
Return on Equity (ROE) | 38.12% |
Return on Assets (ROA) | 23.60% |
Return on Invested Capital (ROIC) | 28.12% |
Return on Capital Employed (ROCE) | 38.86% |
Revenue Per Employee | 3.70M |
Profits Per Employee | 835,309 |
Employee Count | 417 |
Asset Turnover | 1.23 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:544453 has paid 119.09 million in taxes.
Income Tax | 119.09M |
Effective Tax Rate | 25.48% |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | 432,300 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544453 had revenue of INR 1.54 billion and earned 348.32 million in profits. Earnings per share was 33.47.
Revenue | 1.54B |
Gross Profit | 609.61M |
Operating Income | 472.43M |
Pretax Income | 467.42M |
Net Income | 348.32M |
EBITDA | 509.82M |
EBIT | 472.43M |
Earnings Per Share (EPS) | 33.47 |
Balance Sheet
The company has 57.11 million in cash and 142.85 million in debt, giving a net cash position of -85.74 million or -6.06 per share.
Cash & Cash Equivalents | 57.11M |
Total Debt | 142.85M |
Net Cash | -85.74M |
Net Cash Per Share | -6.06 |
Equity (Book Value) | 1.09B |
Book Value Per Share | 104.56 |
Working Capital | 210.26M |
Cash Flow
In the last 12 months, operating cash flow was 239.10 million and capital expenditures -153.04 million, giving a free cash flow of 86.06 million.
Operating Cash Flow | 239.10M |
Capital Expenditures | -153.04M |
Free Cash Flow | 86.06M |
FCF Per Share | 6.08 |
Margins
Gross margin is 39.55%, with operating and profit margins of 30.65% and 22.60%.
Gross Margin | 39.55% |
Operating Margin | 30.65% |
Pretax Margin | 30.32% |
Profit Margin | 22.60% |
EBITDA Margin | 33.08% |
EBIT Margin | 30.65% |
FCF Margin | 5.58% |
Dividends & Yields
BOM:544453 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.00% |
Shareholder Yield | n/a |
Earnings Yield | 7.95% |
FCF Yield | 1.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BOM:544453 has an Altman Z-Score of 3.19 and a Piotroski F-Score of 4.
Altman Z-Score | 3.19 |
Piotroski F-Score | 4 |